Pulse Biosciences Statistics Share Statistics Pulse Biosciences has 67.27M
shares outstanding. The number of shares has increased by 9.76%
in one year.
Shares Outstanding 67.27M Shares Change (YoY) 9.76% Shares Change (QoQ) 9.36% Owned by Institutions (%) 8.46% Shares Floating 12.6M Failed to Deliver (FTD) Shares 1,259 FTD / Avg. Volume 0.75%
Short Selling Information The latest short interest is 2.44M, so 3.62% of the outstanding
shares have been sold short.
Short Interest 2.44M Short % of Shares Out 3.62% Short % of Float 15.77% Short Ratio (days to cover) 12.99
Valuation Ratios The PE ratio is -18.97 and the forward
PE ratio is -11.82.
Pulse Biosciences's PEG ratio is
-4.17.
PE Ratio -18.97 Forward PE -11.82 PS Ratio 0 Forward PS 100.2 PB Ratio 8.85 P/FCF Ratio -27.88 PEG Ratio -4.17
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Pulse Biosciences.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 11.88,
with a Debt / Equity ratio of 0.08.
Current Ratio 11.88 Quick Ratio 11.88 Debt / Equity 0.08 Debt / EBITDA -0.17 Debt / FCF -0.24 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-714.47K Employee Count 75 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -4.86% in the
last 52 weeks. The beta is 1.6, so Pulse Biosciences's
price volatility has been higher than the market average.
Beta 1.6 52-Week Price Change -4.86% 50-Day Moving Average 15.69 200-Day Moving Average 17.37 Relative Strength Index (RSI) 42.9 Average Volume (20 Days) 166,959
Income Statement
Revenue n/a Gross Profit n/a Operating Income -56.26M Net Income -53.59M EBITDA -52.41M EBIT -53.59M Earnings Per Share (EPS) -0.92
Full Income Statement Balance Sheet The company has 118.04M in cash and 8.9M in
debt, giving a net cash position of 109.14M.
Cash & Cash Equivalents 118.04M Total Debt 8.9M Net Cash 109.14M Retained Earnings -390.5M Total Assets 133.38M Working Capital 113.15M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -36.34M
and capital expenditures -125K, giving a free cash flow of -36.47M.
Operating Cash Flow -36.34M Capital Expenditures -125K Free Cash Flow -36.47M FCF Per Share -0.62
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
